Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration
Abstract Adjuvants play a crucial role in enhancing vaccine efficacy. Although several adjuvants have been approved, there remains a demand for safer and more effective adjuvants for nasal vaccines. Here, we identified calboxyvinyl polymer (CVP) as a superior mucosal vaccine adjuvant from pharmaceut...
Saved in:
| Main Authors: | Eita Sasaki, Hideki Asanuma, Haruka Momose, Jun–ichi Maeyama, Saya Moriyama, Noriyo Nagata, Tadaki Suzuki, Isao Hamaguchi, Hideki Hasegawa, Yoshimasa Takahashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01086-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico
by: Daisuke Kuroda, et al.
Published: (2025-12-01) -
A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.
by: Jun-ichi Maeyama, et al.
Published: (2014-01-01) -
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients
by: Kenta Takahashi, et al.
Published: (2025-05-01) -
Targeting mucosal immunity in malaria control: the underexplored role of IgA
by: Haruna Muwonge, et al.
Published: (2025-06-01) -
Impaired mucosal IgA response in patients with severe COVID-19
by: Melyssa Yaugel-Novoa, et al.
Published: (2024-12-01)